Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text answering member label
creator	label
publisher
tabling member	label

Search

1010153

	human indexable
	published
	registered interest
	answer date	22/11/2018
	date	19/11/2018
	date tabled	19/11/2018
	ddp created	20/11/2018 01:38:52
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/11/2018 15:45:13 22/11/2018 18:14:01
	hansard heading	Eating Disorders
	house id	1
	identifier	192754
	legislature	25259
	parliament number	57
	question first answered	22/11/2018 17:42:15
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 October 2018 to Question 177617 on Eating disorders, if he will list the 70 new or extended community services providing specialist community-based care for eating disorders that are open or in development by the local authority in which they are based.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 192754
	type	WrittenParliamentaryQuestion
	uin	192754
	version	2
	written parliamentary question type	NamedDay
	answer	answer answer text <p>This information is not available by local authority.</p> answering member 4065 label Biography information for Dame Jackie Doyle-Price
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1012292

	human indexable
	published
	registered interest
	answer date	27/11/2018
	date	22/11/2018
	date tabled	22/11/2018
	ddp created	22/11/2018 18:40:05
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	22/11/2018 18:55:44 27/11/2018 15:22:01
	hansard heading	Copyright: EU Action
	house id	1
	identifier	194603
	legislature	25259
	parliament number	57
	question first answered	27/11/2018 14:50:26
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the Trilogue process in relation to the EU Directive on Copyright in the Digital Single Market, whether the Government plans to support the inclusion of provisions to ensure that creators receive fair remuneration for the use of their works.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 194603
	type	WrittenParliamentaryQuestion
	uin	194603
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The Government supports the principle that creators should be fairly rewarded for their work whilst ensuring that we continue to encourage investment in new content and innovative services. We are engaging with our European partners to achieve these aims during Trilogue negotiations on this Directive.</p> answering member 3980 label Biography information for Mr Sam Gyimah
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1012293

	human indexable
	published
	registered interest
	answer date	27/11/2018
	date	22/11/2018
	date tabled	22/11/2018
	ddp created	22/11/2018 18:40:07
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	22/11/2018 18:55:46 27/11/2018 16:15:03
	hansard heading	Copyright: EU Countries
	house id	1
	identifier	194604
	legislature	25259
	parliament number	57
	question first answered	27/11/2018 15:43:32
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential effect of the UK leaving the EU on the reciprocal relationships the UK has with the EU that enable collective management organisations to collect royalties from EU countries and distribute to creators in the UK.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 194604
	type	WrittenParliamentaryQuestion
	uin	194604
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The Government has considered this issue in the context of its Brexit analysis. It has concluded that the reciprocal arrangements between UK Collective Management Organisations (CMOs) and EU CMOs to collect royalties from EU countries and distribute to creators in the UK are private commercial agreements which are expected to continue after the UK has exited the European Union.</p> answering member 3980 label Biography information for Mr Sam Gyimah
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1012294

	human indexable
	published
	registered interest
	answer date	27/11/2018
	date	22/11/2018
	date tabled	22/11/2018
	ddp created	22/11/2018 18:40:09
	answering body	Department for Digital, Culture, Media and Sport
	question status	Tabled
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	ddp modified	22/11/2018 18:55:48 27/11/2018 19:50:02
	hansard heading	Arts: EU Grants and Loans
	house id	1
	identifier	194605
	legislature	25259
	parliament number	57
	question first answered	27/11/2018 19:18:35
	question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether the Government plans to remain part of Creative Europe after the current funding period concludes in 2020.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 194605
	type	WrittenParliamentaryQuestion
	uin	194605
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text The UK will always be a European country that advocates for cultural diversity as part of its global identity and is committed to continuing its contribution to and support of European culture. The Government has been clear that will be explore participation in any successor programme to Creative Europe. Where EU funding programmes are to the UK and EU's joint advantage, we want to discuss continued participation as part of the negotiations. Ultimately, the decision on which programmes are in the UK’s interests will be decided as part of the future partnership negotiations, which are ongoing. answering member 4115 label Biography information for Margot James
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1016320

	human indexable
	published
	registered interest
	answer date	03/12/2018
	date	28/11/2018
	date tabled	28/11/2018
	ddp created	28/11/2018 20:13:21
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	28/11/2018 20:19:40 03/12/2018 19:00:05
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	identifier	196736
	legislature	25259
	parliament number	57
	question first answered	03/12/2018 18:29:34
	question text	To ask the Secretary of State for Health and Social Care, with reference to the transition period set out in the agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, whether the Medicines and Healthcare Products Regulatory Agency will retain its status as a competent authority; and whether existing CE marks assigned under that agency will be valid from 29 March 2019 until the end of that transition period.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 196736
	type	WrittenParliamentaryQuestion
	uin	196736
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The agreement of an implementation period will ensure that access to medicines and medical devices continues, and patient safety is maintained, in both the United Kingdom and European Union markets.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be the UK competent authority during this period.</p><p> </p><p>For medical devices, CE marks are assigned by notified bodies (rather than competent authorities such as the MHRA), and during the implementation period UK notified bodies will continue to conduct third-party conformity assessment in the UK, and the results of these tests will continue to be used and recognised for both the UK and EU markets.</p> answering member 4065 label Biography information for Dame Jackie Doyle-Price
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1020404

	human indexable
	published
	registered interest
	answer date	10/12/2018
	date	05/12/2018
	date tabled	05/12/2018
	ddp created	05/12/2018 21:56:26
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/12/2018 22:15:42 10/12/2018 14:44:03
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	identifier	199325
	legislature	25259
	parliament number	57
	question first answered	10/12/2018 14:12:25
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under the EU (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during the period covered by the Agreement.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 199325
	type	WrittenParliamentaryQuestion
	uin	199325
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> answering member 4065 label Biography information for Dame Jackie Doyle-Price
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1020405

	human indexable
	published
	registered interest
	answer date	10/12/2018
	date	05/12/2018
	date tabled	05/12/2018
	ddp created	05/12/2018 21:56:30
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	05/12/2018 22:15:44 10/12/2018 16:20:03
	hansard heading	Medicines and Healthcare products Regulatory Agency
	house id	1
	identifier	199326
	legislature	25259
	parliament number	57
	question first answered	10/12/2018 15:48:34
	question text	To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA) and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under EU Regulations (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during that period.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 199326
	type	WrittenParliamentaryQuestion
	uin	199326
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as an EU competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p><strong></strong><br><br></p><p> </p> answering member 3977 label Biography information for Chris Heaton-Harris
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

179157

	human indexable
	published
	registered interest
	answer date	23/02/2015
	date	11/02/2015
	date tabled	11/02/2015
	ddp created	11/02/2015 23:35:02
	ddp modified	23/02/2015 17:10:06
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Finance
	house id	1
	identifier	224148
	legislature	25259
	parliament number	55
	question first answered	23/02/2015 16:38:42
	question text	To ask the Secretary of State for Health, when he plans to publish the full reports by KPMG he commissioned into the health economies of (a) Staffordshire, (b) Eastern Cheshire, (c) South West London, (d) North East London, (e) Cumbria, (f) Mid Essex, (g) Cambridge and Peterborough, (h) Leicestershire, (i) Northamptonshire, (j) East Sussex and (k) Devon.
	session	2014/15
	session number	4
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2014/15 224148
	type	WrittenParliamentaryQuestion
	uin	224148
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>As part of NHS England, NHS Trust Development Authority (TDA) and Monitor’s joint project to support 11 challenged local health economies develop clinically and financially sustainable five-year strategic plans, four consultancy firms (including KPMG) were commissioned to support the local areas with the development and strengthening of their plans.</p><p> </p><p> </p><p> </p><p>Reports were provided by the consultants to support the project’s Programme Board, consisting of NHS England, TDA and Monitor, to manage the contracts and ensure that the service specification was being met.</p><p> </p><p> </p><p> </p><p>Work is ongoing based on the contents of these reports and there are a number of steps that have to be undertaken in each of the local health economies before these reports can be released: the production of the five-year strategic plan, consideration of the plan, consultation on possible reforms to the health economy, recommendations for possible reforms following consultation, and implementation of recommendations.</p><p> </p><p> </p><p> </p><p>To release the reports ahead of the steps identified above being completed would be likely to prejudice their outcome. The timescales for the above processes will be different in each of the 11 areas and, as the strategic plans are produced, they are made available from the relevant clinical commissioning group websites through their board papers.</p><p> </p> answering member 3918 label Biography information for Jane Ellison
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

179165

	human indexable
	published
	registered interest
	answer date	23/02/2015
	date	11/02/2015
	date tabled	11/02/2015
	ddp created	11/02/2015 23:35:32
	ddp modified	23/02/2015 17:10:08
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Finance
	house id	1
	identifier	224177
	legislature	25259
	parliament number	55
	question first answered	23/02/2015 16:38:42
	question text	To ask the Secretary of State for Health, if he will place in the Library copies of the full reports by KPMG he has commissioned into the health economies of (a) Staffordshire, (b) Eastern Cheshire, (c) South West London, (d) North East London, (e) Cumbria, (f) Mid-Essex, (g) Cambridge and Peterborough, (h) Leicestershire, (i) Northamptonshire, (j) East Sussex and (k) Devon.
	session	2014/15
	session number	4
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2014/15 224177
	type	WrittenParliamentaryQuestion
	uin	224177
	version	2
	written parliamentary question type	NamedDay
	answer	answer answer text <p>As part of NHS England, NHS Trust Development Authority (TDA) and Monitor’s joint project to support 11 challenged local health economies develop clinically and financially sustainable five-year strategic plans, four consultancy firms (including KPMG) were commissioned to support the local areas with the development and strengthening of their plans.</p><p> </p><p> </p><p> </p><p>Reports were provided by the consultants to support the project’s Programme Board, consisting of NHS England, TDA and Monitor, to manage the contracts and ensure that the service specification was being met.</p><p> </p><p> </p><p> </p><p>Work is ongoing based on the contents of these reports and there are a number of steps that have to be undertaken in each of the local health economies before these reports can be released: the production of the five-year strategic plan, consideration of the plan, consultation on possible reforms to the health economy, recommendations for possible reforms following consultation, and implementation of recommendations.</p><p> </p><p> </p><p> </p><p>To release the reports ahead of the steps identified above being completed would be likely to prejudice their outcome. The timescales for the above processes will be different in each of the 11 areas and, as the strategic plans are produced, they are made available from the relevant clinical commissioning group websites through their board papers.</p><p> </p> answering member 3918 label Biography information for Jane Ellison
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

223300

	human indexable
	published
	registered interest
	answer date	27/02/2015
	date	24/02/2015
	date tabled	24/02/2015
	ddp created	24/02/2015 23:16:46
	ddp modified	05/03/2015 16:43:09
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Finance
	house id	1
	identifier	225293
	legislature	25259
	parliament number	55
	question first answered	05/03/2015 16:11:17
	question text	To ask the Secretary of State for Health, whether the consultancy reports he has commissioned into the challenged local health economy of (a) Staffordshire, (b) Eastern Cheshire, (c) South West London, (d) North East London, (e) Cumbria, (f) Mid Essex, (g) Cambridge and Peterborough, (h) Leicestershire, (i) Northamptonshire, (j) East Sussex and (k) Devon has been completed; and when copies of each completed report were delivered to (i) the project's Joint Programme Board, (ii) NHS England, (iii) the Trust Development Authority, (iv) Monitor and (v) his Department.
	session	2014/15
	session number	4
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2014/15 225293
	type	WrittenParliamentaryQuestion
	uin	225293
	version	2
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The work to support the 11 challenged health economies was commissioned jointly by Monitor, NHS Trust Development Authority and NHS England.</p><p> </p><p> </p><p> </p><p>Consultancy firms were not commissioned to produce reports on the local health economies, as described in the question, but to support the local health economies with the development and strengthening of their strategic plans.</p><p> </p> answering member 3918 label Biography information for Jane Ellison
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly